Medinotec Inc. (MDNC) Financial Statements (2025 and earlier)

Company Profile

Business Address OFFICE 202, GEZERI BUILDING, NAIF
DUBAI, 48803
State of Incorp. NV
Fiscal Year End February 29
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

11/30/2024
Q3
8/31/2024
Q2
5/31/2024
Q1
2/29/2024
Q4
11/30/2023
Q3
8/31/2023
Q2
5/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,7582,5192,8092,6792,8392,710
Cash and cash equivalent2,7582,5192,8092,6792,8392,710
Receivables66435959076180241
Inventory, net of allowances, customer advances and progress billings1,272958863712636489
Inventory1,272958863712636489
Other current assets10199117127180186
Other undisclosed current assets107     
Total current assets:4,9023,9354,3793,5943,8343,627
Noncurrent Assets
Operating lease, right-of-use asset535762   
Property, plant and equipment327316320342360361
Other undisclosed noncurrent assets14144356736708
Total noncurrent assets:3943874253981,0961,069
TOTAL ASSETS:5,2964,3224,8043,9924,9304,696
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,53774580233511079
Accounts payable1,343511609222
Accrued liabilities392179526542
Other undisclosed accounts payable and accrued liabilities1552141142814435
Provision for loss on contracts  23    
Other undisclosed current liabilities294262142
Total current liabilities:1,56677282733612481
Noncurrent Liabilities
Long-term debt and lease obligation1,1721,2661,770   
Long-term debt, excluding current maturities1,1721,2661,770   
Liabilities, other than long-term debt283440   
Operating lease, liability283440   
Other undisclosed noncurrent liabilities    1,5812,2391,992
Total noncurrent liabilities:1,2001,3001,8101,5812,2391,992
Total liabilities:2,7662,0722,6371,9172,3632,073
Equity
Equity, attributable to parent, including:2,5302,2502,1672,0752,5672,623
Common stock121212121212
Additional paid in capital3,2963,2963,2963,2963,2963,296
Accumulated other comprehensive income919610010712129
Other undisclosed equity, attributable to parent(869)(1,154)(1,241)(1,340)(753)(814)
Total equity:2,5302,2502,1672,0752,5672,623
TOTAL LIABILITIES AND EQUITY:5,2964,3224,8043,9924,9304,696

Income Statement (P&L) ($ in thousands)

11/30/2024
Q3
8/31/2024
Q2
5/31/2024
Q1
2/29/2024
Q4
11/30/2023
Q3
8/31/2023
Q2
5/31/2023
Q1
Revenues1,8042,3274,3002,003351416
Cost of revenue(971)  (1,139)(61)(98)
Other undisclosed gross profit  (1,399)(2,278)   
Gross profit:8339282,022864290318
Operating expenses(398)6591,227(606)(234)277
Other undisclosed operating loss  (1,318)(2,453)  (554)
Operating income:4362697962585641
Nonoperating expense(31)(55)(729)(687)(87)(21)
Other nonoperating income (expense)141(22)(6)(30)31
Interest and debt expense    (67)7166
Income (loss) from continuing operations before equity method investments, income taxes:40521466(496)3986
Other undisclosed income (loss) from continuing operations before income taxes    67(71)(66)
Income (loss) from continuing operations before income taxes:40521466(429)(32)20
Income tax expense (127)(31)(63)(12)(2)
Net income (loss):4058735(492)(44)18
Other undisclosed net income (loss) attributable to parent (120) (151) 114
Net income (loss) available to common stockholders, diluted:28587(116)(492)(33)22

Comprehensive Income ($ in thousands)

11/30/2024
Q3
8/31/2024
Q2
5/31/2024
Q1
2/29/2024
Q4
11/30/2023
Q3
8/31/2023
Q2
5/31/2023
Q1
Net income (loss):4058735(492)(44)18
Other comprehensive income (loss)   610(23)(2)
Other undisclosed comprehensive loss   (91)   
Comprehensive income (loss):405876(492)(67)17
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(126)(4)(151) 1150
Comprehensive income (loss), net of tax, attributable to parent:28083(145)(492)(56)67

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: